Quote:
Originally Posted by Conductor71
Even more interesting is that a trial is starting for a subcutaneous levodopa pump this winter. My doctor informed me that I may be able to switch out into that trial; that would be scads less cumbersome were it to work!
If anyone has any questions, I will gladly check with the lead researcher.
Oh one last tidbit. The Duodopa pump has been in trial since 2000 in the US! This means there are people who have been on it for 14 years and are still on it with no adverse effects. Unbelievable that it is taking this long...
|
Laura, with all of your knowledge and the research that you do, I'm sure you'll make the right decision for yourself.
Regarding the subcutaneous pump, I'm aware of two different companies researching this. I've seen presentations by both and have spoken with the CEOs and research teams, and they are quite interesting. I believe the one you are referring too would be Neuroderm, the Israeli company developing a L/C pump-patch. The product is really amazing. It's smaller than a credit card, has a reservoir and delivers the drug via a series of micro-needles. They are beginning a Phase II study soon. The Phase I safety and tolerability results were great and they showed steady levodopa blood plasma levels. Some wall street VCs I know think this could be a blockbuster. Of course, it's several years away from possible approvals, so it may be worth looking into the trial if possible.
Best of luck with whatever route you take!!